Renal replacement therapy and bone mineral metabolism
Mineral bone disturbances are common in chronic kidney disease (CKD), and associated with significant risk of mortality and morbidity in patients on renal replacement therapy (RRT). Surrogate biomarkers of bone turnover such as parathyroid hormone (PTH), phosphate, calcium and Vitamin D are used to...
| Main Author: | |
|---|---|
| Published: |
University of Glasgow
2019
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.768738 |